Patent ID: 11958879
Assignee: ENANTA PHARMACEUTICALS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC C

Claim 0:
1. A compound represented by Formula (IV) or a pharmaceutically acceptable salt thereof:, wherein:
Ra is selected from the group consisting of:
1) Hydrogen;
2) Substituted or unsubstituted —C1-C6 alkoxy;
3) Substituted or unsubstituted —C1-C8 alkyl;
4) Substituted or unsubstituted —C2-C8 alkenyl;
5) Substituted or unsubstituted —C2-C8 alkynyl;
6) Substituted or unsubstituted arylalkyl;
7) Substituted or unsubstituted aryl; and
8) Substituted or unsubstituted C3-C6-cycloalkyl;

Rb is selected from the group consisting of:
1) Hydrogen;
2) Substituted or unsubstituted —C1-C8 alkyl;
3) Substituted or unsubstituted —C2-C8 alkenyl;
4) Substituted or unsubstituted —C2-C8 alkynyl;
5) Substituted or unsubstituted arylalkyl; and
6) Substituted or unsubstituted aryl;

or Ra and Rb are taken together with the nitrogen atom to which they are attached to form a heterocyclic ring; and
m is selected from 0, 1, 2 and 3.